PT  - JOURNAL ARTICLE
AU  - Sullivan, Brynne A.
AU  - Mesner, Ian G.
AU  - Niestroy, Justin
AU  - Lake, Douglas E.
AU  - Fairchild, Karen D.
AU  - Moorman, J. Randall
TI  - Can machine learning or deep learning discover novel signatures of illness in continuous cardiorespiratory monitoring data?
AID  - 10.1101/2024.02.03.24302230
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.02.03.24302230
4099  - http://medrxiv.org/content/early/2024/02/04/2024.02.03.24302230.short
4100  - http://medrxiv.org/content/early/2024/02/04/2024.02.03.24302230.full
AB  - Background Cardiorespiratory deterioration due to sepsis is a leading cause of morbidity and mortality for extremely premature infants with very low birth weight (VLBW, birthweight <1500g). Abnormal heart rate (HR) patterns precede the clinical diagnosis of late-onset sepsis in this population. Decades ago, clinicians recognized a pattern of reduced HR variability and increased HR decelerations in electrocardiogram tracings of septic preterm infants. A predictive logistic regression model was developed from this finding using mathematical algorithms that detect this signature of illness. Display of this model as the fold increase in risk of imminent sepsis reduced mortality in a large randomized trial. Here, we sought to determine if machine learning or deep learning approaches would identify this uncommon but distinctive signature of sepsis in VLBW infants.Methods We studied VLBW infants admitted from 2012 to 2021 to a regional Level IV NICU. We collected one-hour HR time series data from bedside monitoring sampled at 0.5 Hz (n=300 HR values per series) throughout the NICU admission. First, we applied the principles of highly comparative time series analysis (HCTSA) to generate many mathematical time series features and combined them in a machine learning model. Next, we used deep learning in the form of a convolutional neural network on the raw data to learn the HR features. The output was a set of HR records determined by HCTSA or deep learning to be at high risk for imminent sepsis.Results We analyzed data from 566 infants with 61 episodes of sepsis. HCTSA and deep learning models predicted sepsis with high out-of-sample validation metrics. The riskiest records determined by both approaches demonstrated the previously identified HR signatures-reduced variability and increased decelerations.Conclusions We tested the ability of unguided machine learning approaches to detect the novel HR signature of sepsis in VLBW infants previously identified by human experts. Our main finding is that the computerized approach returned the same result - it identified heart rate characteristics of reduced variability and transient decelerations. We conclude that unguided machine learning can be as effective as human experts in identifying even a very rare phenotype in clinical data.Competing Interest StatementCompeting interests: JRM and DEL own stock in Medical Predictive Science Corporation, Charlottesville, VA; JRM consults for Nihon Kohden Digital Health Solutions, Irvine, CA, with proceeds donated to the University of Virginia Medical School FoundationFunding StatementThis study was funded by R01 HD092071Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Virginia Institutional Review Board gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors